Education, Science, Technology, Innovation and Life
Open Access
Sign In

Research on Phage-based Influenza Vaccine Utilizing Hemagglutinin Protein

Download as PDF

DOI: 10.23977/phpm.2025.050118 | Downloads: 5 | Views: 264

Author(s)

Zhiyi Yang 1, Kunjie Ma 1, Jiupian Yang 1

Affiliation(s)

1 Department of Pathogen Biology and Immunology, Kunming Medical University, Kunming, Yunnan Province, China

Corresponding Author

Jiupian Yang

ABSTRACT

Influenza virus is a major threat to global public health, and its high variability and diversity bring great challenges to vaccine development. Hemagglutinin (HA) protein, as an important surface antigen of influenza virus, plays a key role in virus invasion and immune escape, and is the focus of vaccine development. Although the traditional influenza vaccine has certain effect, it is unable to cope with the rapid mutation of the virus. As a new technology, phage vaccine uses phage display platform to display foreign antigens and induce specific immune response. This article summarizes the structure, function and variability of HA protein of influenza virus, and the limitations of traditional influenza vaccine. Then the basic principle of phage display technology and its application potential in vaccine research and development are introduced. Subsequently, the research and development process, immunogenicity evaluation and advantages of influenza phage vaccine based on HA protein are expounded, and the challenges it faces are analyzed. Finally, the potential of phage vaccine in influenza prevention and control is summarized and the future research direction is prospected.

KEYWORDS

Influenza virus; HA protein; Phage vaccine; Immunogenicity

CITE THIS PAPER

Zhiyi Yang, Kunjie Ma, Jiupian Yang, Research on Phage-based Influenza Vaccine Utilizing Hemagglutinin Protein. MEDS Public Health and Preventive Medicine (2025) Vol. 5: 122-127. DOI: http://dx.doi.org/10.23977/phpm.2025.050118.

REFERENCES

[1] Dong Shanshan, Wang Peng, Zhong Youhong, et al. Isolation and Identification of Plague Phages from a Domestic Rodent Plague Focus in Pu'er City, Yunnan Province [J]. China Tropical Medicine, 2020, 20(08): 693-696.
[2] Hou Xueying, Hu Zhuowei, Cui Bing. Application of Phage Display Technology in Drug Development [J]. Acta Pharmaceutica Sinica, 2018, 53(08): 1280-1289.
[3] Wu Shichen, Deng Qiong, Zhang Ruidan, et al. Study on the Effect of Influenza Vaccine in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease [J]. Journal of Clinical Pulmonary Medicine, 2018, 23(03): 467-470.
[4] Zhong Shuyi, Wen Simin, Li Mao, et al. Association between Immune-related Gene Polymorphisms and Influenza Vaccine Response [J]. Chinese Journal of Vaccines and Immunization, 2019, 25(06): 736-742.
[5] Wen Jiaxin, Cheng Xiaoqing, Bao Changjun, et al. Cost-Utility Analysis of Seasonal Influenza Vaccination for Pregnant Women in Jiangsu Province Using a Decision Tree Markov Model [J]. Chinese Journal of Vaccines and Immunization, 2023, 29(4): 427-431.
[6] Huang Xun, Feng Lumeng, Du Xiaoxing, et al. Guidelines for Influenza Vaccination of Healthcare Workers in Chinese Medical Institutions [J]. Chinese Journal of Infection Control, 2023, 22(8): 871-885.
[7] Yang Xinyan, Wo Enkang, Zhang Ruxuan, et al. Research Progress on Universal Vaccines Based on the Hemagglutinin Stem Domain of Influenza Viruses [J]. Journal of Medical Research, 2018, 47(03): 153-156.
[8] Wang Tingting, Liu Ze. Research Progress on the Impact of N-Glycosylation of Influenza Virus Hemagglutinin Protein on Immune Response and Mass Spectrometry Analysis [J]. Chinese Journal of Vaccines and Immunization, 2022, 28(06): 736-740.
[9] Meng Wei, Zhang Lei, Huang Jinhai. Research Progress on Universal Vaccines Based on Influenza Virus Hemagglutinin [J]. Hubei Agricultural Sciences, 2021, 60(14): 10-16.
[10] Zhou Yun, Fang Chao, Wang Li, et al. Effects of Different Adjuvants Combined with Antigen Epitope Fusion Proteins on the Immunogenicity of Influenza Vaccines [J]. Chinese Journal of Biologicals, 2021, 34(03): 255-259.
[11] Yang Jiao, Wang Zijian, Liu Pan, et al. Characterization of a Plague Phage Isolated from Sewage in a Wild Rodent Plague Focus [J]. Chinese Journal of Pathobiology, 2023, 18(6): 657-661.
[12] Liao Wenjing, Fan Renfeng, Zhang Jikai. Research Progress on the Immunogenicity, Safety, and Universal Influenza Vaccines [J]. Chinese Journal of Vaccines and Immunization, 2023, 29(4): 483-492.
[13] Zhou Sijia, Chen Ziying, Jiang Xin, et al. Survey on Knowledge, Attitude, and Practice of Influenza Vaccination and Driving Factors for Vaccination among Young and Middle-aged Adults [J]. Chinese Journal of Disease Control & Prevention, 2024, 28(5): 540-546.
[14] Wu Yushu, Sun Weiyang, Zhao Menglin, et al. Optimization of Culture Process for B-type Influenza Vaccine Candidate Strain on MDCK Suspension Cells [J]. Chinese Journal of Virology, 2024, 40(2): 283-292.
[15] Xu Juan, Chao Tingting, Xiao Jiaqi, et al. Analysis of Influenza Vaccination Coverage Among People Aged ≥60 Years in Suzhou Before and After the COVID-19 Pandemic [J]. South China Journal of Preventive Medicine, 2023, 49(7): 936-939.
[16] Wu Xue, Deng Hong, Chen Li. Application and Analysis of the Proportional Imbalance Method in Signal Detection of Adverse Reactions to H1N1 Influenza Vaccines [J]. Central South Pharmacy, 2019, 17(06): 806-810.
[17] Hu Keke, Liu Xuping, Cai Haibo, et al. Optimization of Avian Influenza Vaccine Production Process Based on Box-Behnken Experimental Design and Response Surface Methodology [J]. Journal of Chemical Engineering of Chinese Universities, 2019, 33(02): 394-399.
[18] Li Cunxiang, Qi Zhizhen, Zhang Qingwen, et al. Growth Phenotypic Characteristics of Wild-type Plague Phage in Experimental Environments [J]. China Tropical Medicine, 2023, 23(7): 720-724.

Downloads: 4250
Visits: 239169

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.